Medtronic PLC (NYSE:MDT)

93.03
Delayed Data
As of May 24
 +1.39 / +1.52%
Today’s Change
81.66
Today|||52-Week Range
100.15
+2.28%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
--

Company Description

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Contact Information

Medtronic Plc
20 On Hatch
Dublin Dublin 2
P:(531) 438-1700
Investor Relations:
(763) 505-2692

Employees

Shareholders

Mutual fund holders49.26%
Other institutional34.29%
Individual stakeholders0.16%

Top Executives

Omar S. IshrakChairman & Chief Executive Officer
Mark PloofSenior Vice President-Global Operations
Karen L. ParkhillChief Financial Officer & Executive Vice President
Richard E. KuntzChief Scientific, Clinical & Regulatory Officer
Geoffrey Straub MarthaExecutive VP & President-Restorative Therapies